- The new moleculary targeted drug for the treatment of non small cell lung cancer (NSCLC)2011 | Faculty of Medicine in Pilsen
- Efficiency and safety of pemetrexed and cisplatin therapy in the adenocarcinoma and large cell cancer types of advanced non-small cell lung cancer (NSCLC) +12012 | Publication without faculty affiliation
- Gemcitabine in non-small cell lung cancer (NSCLC)2000 | Third Faculty of Medicine
- Prognostic and predictive markers in non-small cell lung cancer (NSCLC) - 1st part Summary Prognostic and predictive markers in non-small cell lung cancer (NSCLC) - 1st part Summary Prognostic and predictive markers in non-small cell lung cancer (NSCLC) - 1st part Summary PrognostiPrognostic and predictive markers in non-small cell lung cancer (NSCLC) - 1st part Summary Prognostic and predictive markers in non-small cell lung cancer (NSCLC) - 1st part2019 | Faculty of Medicine in Pilsen
- Individualized therapy in non small cell lung Cancer (NSCLC)2011 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- The role of MonoTotal in the primary diagnosis, prognosis and follow-up of patients with non-small cell lung cancer (NSCLC)2011 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Multiplicity of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC) patients treated with tyrosine kinase inhibitors2010 | Central Library of Charles University
- Multiplicity of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC) patients treated with tyrosine kinase inhibitors2010 | Faculty of Medicine in Pilsen
- The role of monototal in the primary diagnosis, prognosis and follow-up of patients with non-small cell lung cancer (NSCLC)2011 | First Faculty of Medicine
- Prognostic and predictive markers in non-small cell lung cancer (NSCLC) - 2nd part Summary2019 | Faculty of Medicine in Pilsen
- CCL2, CCL8, CXCL12 chemokines in resectable non-small cell lung cancer (NSCLC)2023 | First Faculty of Medicine, Central Library of Charles University, Third Faculty of Medicine
- Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease2009 | Central Library of Charles University
- Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease2009 | Faculty of Medicine in Pilsen
- Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease2009 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- The use of tumor markers in predicting reccurence of non-small cell lung cancer (NSCLC) after radical surgery2007 | Central Library of Charles University
- Interdisciplinary consensus for predictive investigations in non-small cell lung cancer (NSCLC) - update 20122012 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- The use of tumor markers in predicting reccurence of non-small cell lung cancer (NSCLC) after radical surgery2007 | Faculty of Medicine in Pilsen, Central Library of Charles University
- The use of tumor markers in predicting reccurence of non-small cell lung cancer (NSCLC) after radical surgery2007 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Research Report University Hospital of the clinical trial 1200.55Publication without faculty affiliation
- Concurrent radiochemotherapy in advanced non-small cell lung cancer (NSCLC): impact of radiotherapy timing on the treatment outcomePublication without faculty affiliation
- A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)2012 | Third Faculty of Medicine
- Weekly paclitaxel and carboplatin chemotherapy with concomitant radioterapy in locally advanced inoperable non-small cell lung cancer (NSCLC)Publication without faculty affiliation
- Monitoring of the expensive pneumooncological tratment of the advanced non-small cell lung cancer (NSCLC) in the 1st line in the TULUNG registry in the Czech Republic2012 | First Faculty of Medicine, Third Faculty of Medicine
- Gemcitabin, cisplatin (GP) versus vinorelbine, ifosfamide, cisplatin (NIP) in locally advanced non-small cell lung cancer (NSCLC)2001 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Locally advanced inoperable non-small cell lung cancer (NSCLC) treated by weekly paclitaxel/carboplatin chemotherapy with concomitant radiotherapyPublication without faculty affiliation
- Identification of an optimal algorithm for effective diagnostics of non-small cell lung cancer with ALK gene rearrangement - implementation of the method and practical experiences with routine diagnostics2017 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Randomized Phase 2b Study of Pralatrexate Versus Erlotinib in Patients With Stage IIIB/IV Non-Small-Cell Lung Cancer (NSCLC) After Failure of Prior Platinum-Based Therapy2012 | Third Faculty of Medicine
- First experiences with detecting ALK (anaplastic lymphoma kinase) gene rearrangement and administration of crizotinib in selected patients with non-small cell lung cancer (NSCLC)2012 | Faculty of Medicine in Pilsen
- Treatment of lung cancer with targetable mutations - new drugs and indications2023 | First Faculty of Medicine
